March 11, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to ...

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.

{"0": "Apple___Apple_scab", "1": "Apple___Black_rot", "2": "Apple___Cedar_apple_rust", "3": "Apple___healthy", "4": "Blueberry___healthy", "5": "Cherry_(including ...

Tomato plants are highly susceptible to various diseases that can significantly impact crop yield and quality. Early detection and classification of these diseases are crucial for effective pest ...